Literature DB >> 30862674

The retroviral accessory proteins S2, Nef, and glycoMA use similar mechanisms for antagonizing the host restriction factor SERINC5.

Iqbal Ahmad1, Sunan Li1, Rongrong Li1, Qingqing Chai2, Lixin Zhang1, Bin Wang1, Changqing Yu1, Yong-Hui Zheng3,2.   

Abstract

Serine incorporator 5 (SERINC5) is a recently identified restriction factor that blocks virus entry but is antagonized by three unrelated retroviral accessory proteins. The S2 protein from equine infectious anemia virus (EIAV) has been reported to reduce SERINC5 expression at steady-state levels likely via the endocytic pathway; however, the precise mechanism is still unclear. Here, we investigated how EIAV S2 protein down-regulates SERINC5 compared with down-regulation induced by Nef from HIV-1 and glycoMA proteins from murine leukemia virus (MLV). Using bimolecular fluorescence complementation (BiFC) assay and immunoprecipitation (IP), we detected an interaction between S2 and SERINC5. We found that this interaction relies on the S2 myristoylation site, indicating that it may occur on the plasma membrane. S2 internalized SERINC5 via receptor-mediated endocytosis and targeted it to endosomes and lysosomes, resulting in a ubiquitination-dependent decrease in SERINC5 expression at steady-state levels. Both BiFC and IP detected a glycoMA-SERINC5 interaction, but a Nef-SERINC5 interaction was detected only by BiFC. Moreover, S2 and glycoMA down-regulated SERINC5 more effectively than did Nef. We further show that unlike Nef, both S2 and glycoMA effectively down-regulate SERINC2 and also SERINC5 from Xenopus tropicalis (xSERINC5). Moreover, we detected expression of the equine SERINC5 (eSERINC5) protein and observed that its expression is much weaker than expression levels of SERINC5 from other species. Nonetheless, eSERINC5 had a strong antiviral activity that was effectively counteracted by S2. We conclude that HIV-1, EIAV, and MLV share a similar mechanism to antagonize viral restriction by host SERINC5.
© 2019 Ahmad et al.

Entities:  

Keywords:  EIAV S2; HIV Nef; MLV glycoGag; SERINC5; host-pathogen interaction; innate immunity; restriction factor; viral protein; virus; virus entry

Mesh:

Substances:

Year:  2019        PMID: 30862674      PMCID: PMC6497950          DOI: 10.1074/jbc.RA119.007662

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

1.  Mutations occurring during serial passage of Japanese equine infectious anemia virus in primary horse macrophages.

Authors:  Y H Zheng; H Sentsui; Y Kono; K Ikuta
Journal:  Virus Res       Date:  2000-06       Impact factor: 3.303

2.  Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity.

Authors:  H M Craig; M W Pandori; J C Guatelli
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

3.  The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.

Authors:  Birthe Trautz; Virginia Pierini; Rebecka Wombacher; Bettina Stolp; Amanda J Chase; Massimo Pizzato; Oliver T Fackler
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

4.  The S2 accessory gene of equine infectious anemia virus is essential for expression of disease in ponies.

Authors:  Angela J Fagerness; Maureen T Flaherty; Stephanie T Perry; Bin Jia; Susan L Payne; Frederick J Fuller
Journal:  Virology       Date:  2006-02-28       Impact factor: 3.616

5.  Murine Leukemia Virus Glycosylated Gag Reduces Murine SERINC5 Protein Expression at Steady-State Levels via the Endosome/Lysosome Pathway to Counteract SERINC5 Antiretroviral Activity.

Authors:  Sunan Li; Iqbal Ahmad; Jing Shi; Bin Wang; Changqing Yu; Lixin Zhang; Yong-Hui Zheng
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

6.  HIV-1 Nef Antagonizes SERINC5 Restriction by Downregulation of SERINC5 via the Endosome/Lysosome System.

Authors:  Jing Shi; Ran Xiong; Tao Zhou; Peiyi Su; Xihe Zhang; Xusheng Qiu; Hongmei Li; Sunan Li; Changqing Yu; Bin Wang; Chan Ding; Thomas E Smithgall; Yong-Hui Zheng
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Identification of SERINC5-001 as the Predominant Spliced Isoform for HIV-1 Restriction.

Authors:  Xianfeng Zhang; Tao Zhou; Jie Yang; Yumei Lin; Jing Shi; Xihe Zhang; Dylan A Frabutt; Xiangwei Zeng; Sunan Li; Patrick J Venta; Yong-Hui Zheng
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

8.  Functional Interplay Between Murine Leukemia Virus Glycogag, Serinc5, and Surface Glycoprotein Governs Virus Entry, with Opposite Effects on Gammaretroviral and Ebolavirus Glycoproteins.

Authors:  Yadvinder S Ahi; Shu Zhang; Yashna Thappeta; Audrey Denman; Amin Feizpour; Suryaram Gummuluru; Bjoern Reinhard; Delphine Muriaux; Matthew J Fivash; Alan Rein
Journal:  mBio       Date:  2016-11-22       Impact factor: 7.867

9.  HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation.

Authors:  Annachiara Rosa; Ajit Chande; Serena Ziglio; Veronica De Sanctis; Roberto Bertorelli; Shih Lin Goh; Sean M McCauley; Anetta Nowosielska; Stylianos E Antonarakis; Jeremy Luban; Federico Andrea Santoni; Massimo Pizzato
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

10.  SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef.

Authors:  Yoshiko Usami; Yuanfei Wu; Heinrich G Göttlinger
Journal:  Nature       Date:  2015-09-30       Impact factor: 49.962

View more
  16 in total

1.  CD4 Expression and Env Conformation Are Critical for HIV-1 Restriction by SERINC5.

Authors:  Xihe Zhang; Jing Shi; Xusheng Qiu; Qingqing Chai; Dylan A Frabutt; Richard C Schwartz; Yong-Hui Zheng
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

Review 2.  Multifaceted Roles of TIM-Family Proteins in Virus-Host Interactions.

Authors:  John P Evans; Shan-Lu Liu
Journal:  Trends Microbiol       Date:  2019-11-12       Impact factor: 17.079

3.  Super-Resolution Fluorescence Imaging Reveals That Serine Incorporator Protein 5 Inhibits Human Immunodeficiency Virus Fusion by Disrupting Envelope Glycoprotein Clusters.

Authors:  Yen-Cheng Chen; Chetan Sood; Mariana Marin; Jesse Aaron; Enrico Gratton; Khalid Salaita; Gregory B Melikyan
Journal:  ACS Nano       Date:  2020-06-01       Impact factor: 15.881

Review 4.  HIV-1 restriction by SERINC5.

Authors:  Lucía Cano-Ortiz; Tom Luedde; Carsten Münk
Journal:  Med Microbiol Immunol       Date:  2022-03-25       Impact factor: 3.402

5.  SERINC proteins potentiate antiviral type I IFN production and proinflammatory signaling pathways.

Authors:  Cong Zeng; Abdul A Waheed; Tianliang Li; Jingyou Yu; Yi-Min Zheng; Jacob S Yount; Haitao Wen; Eric O Freed; Shan-Lu Liu
Journal:  Sci Signal       Date:  2021-09-14       Impact factor: 9.517

6.  Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor.

Authors:  Vânia Passos; Thomas Zillinger; Nicoletta Casartelli; Amelie S Wachs; Shuting Xu; Angelina Malassa; Katja Steppich; Hildegard Schilling; Sergej Franz; Daniel Todt; Eike Steinmann; Kathrin Sutter; Ulf Dittmer; Jens Bohne; Olivier Schwartz; Winfried Barchet; Christine Goffinet
Journal:  J Virol       Date:  2019-11-26       Impact factor: 5.103

7.  Proteasomal degradation of human SERINC4: A potent host anti-HIV-1 factor that is antagonized by nef.

Authors:  Xusheng Qiu; Ifeanyichukwu E Eke; Silas F Johnson; Chan Ding; Yong-Hui Zheng
Journal:  Curr Res Virol Sci       Date:  2020-12-08

Review 8.  Membrane Interference Against HIV-1 by Intrinsic Antiviral Factors: The Case of IFITMs.

Authors:  Federico Marziali; Andrea Cimarelli
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

9.  Coelacanth SERINC2 Inhibits HIV-1 Infectivity and Is Counteracted by Envelope Glycoprotein from Foamy Virus.

Authors:  Pavitra Ramdas; Vipin Bhardwaj; Aman Singh; Nagarjun Vijay; Ajit Chande
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

10.  A bipartite structural organization defines the SERINC family of HIV-1 restriction factors.

Authors:  Annachiara Rosa; Cinzia Bertelli; Valerie E Pye; Weston B Struwe; Sarah L Maslen; Robin Corey; Idlir Liko; Mark Hassall; Giada Mattiuzzo; Allison Ballandras-Colas; Andrea Nans; Yasuhiro Takeuchi; Phillip J Stansfeld; J Mark Skehel; Carol V Robinson; Massimo Pizzato; Peter Cherepanov
Journal:  Nat Struct Mol Biol       Date:  2020-01-06       Impact factor: 15.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.